8-K
filed May 28, 2026, 5:15 PM ET
ticker DXCM
CIK 0001093557
other material
confidence high
sentiment neutral
materiality 0.15
DexCom announces results of 2026 Annual Meeting, all proposals approved by stockholders
DEXCOM INC
- Stockholders elected 12 directors to the board, with each director receiving between 265.9M and 313.6M votes for.
- Ratified Deloitte & Touche LLP as independent auditor for FY2026 with 336,046,596 votes for, 373,544 against.
- Advisory say-on-pay proposal on executive compensation approved with 277,111,475 votes for and 36,664,959 against.
- A quorum of 336,525,352 shares (87.2% of outstanding) was present at the May 27, 2026 meeting.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
DEXCOM INC shareholders approved Election of Directors at the 2026-05-27 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-27
Exact text from the filing
Dexcom stockholders elected the following twelve nominees to the Company’s board of directors
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
DEXCOM INC shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-05-27 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-27
Exact text from the filing
Dexcom stockholders ratified the selection by the audit committee of the board of directors of Deloitte & Touche LLP as Dexcom’s independent registered public accounting firm
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
DEXCOM INC shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2026-05-27 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-27
Exact text from the filing
Dexcom stockholders approved, on a non-binding advisory basis, the compensation of Dexcom’s named executive officers
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.